Research materials, selected deliberately
A proposed starting catalog of 5–10 individually reviewed products, shaped by laboratory specifications rather than consumer trends. No product is approved for launch yet.
Texas-based · In development
Research supply.
Evidence first.
WS Peps is developing a peptide research-supply business for verified laboratories and research organizations. Our focus: documented materials, lot traceability, and dependable business support.
Pre-launch. No products or orders are currently available.
Our founding commitments
Built on records.
Not promises of outcomes.
Documentation before dispatch
Lot-specific analytical records and a recorded release decision are planned requirements for every shipment.
Traceability at every step
Our proposed workflow links supplier, receipt, testing, release, and customer order.
Review before availability
Product-specific legal review and provider acceptance must precede any sale.
The planned offer
A considered catalog.
A clear chain of custody.
Start small. Validate the process. Expand only when the evidence and operations support it.
Documentation matched to the material
Planned supplier qualification and product-specific testing, with analytical reports and acceptance criteria. Purity alone does not establish sterility, safety, or suitability for human use.
Support beyond the order
A planned purchasing workflow with institutional account screening, delivery updates, documentation requests, and recorded complaint handling.
The operating standard
Every lot has
a documented path.
a documented path.
Our proposed release workflow keeps inventory unavailable until its release decision is recorded.
- 01Qualify the supplier
- 02Receive and quarantine
- 03Review records and required testing
- 04Record release or rejection
- 05Verify the customer and order
- 06Record the shipped lot
Next chapter · Controlled pilot
Better research supply
starts with listening.
We plan to learn from institutional buyers before opening a small pilot. Purchasing requirements, documentation needs, and ordering workflows will help shape the offer.
Review our commitmentsWho the proposed pilot is for
Verified laboratories and research organizations with documented, legitimate research needs. The target is 3–5 qualified accounts after all launch gates pass—not a current enrollment offer.
Account inquiries and ordering are not yet open. Launch depends on legal review, provider acceptance, lot release, validated operations, and a funded cash plan.